Rare Diseases Symptoms Automatic Extraction
Home
A random Abstract
Our Project
Our Team
Rat model for dominant dystrophic epidermolysis bullosa: glycine substitution reduces collagen VII stability and shows gene-dosage effect.
[dystrophic epidermolysis bullosa]
Dystrophic
epidermolysis
bullosa
,
a
severely
disabling
hereditary
skin
fragility
disorder
,
is
caused
by
mutations
in
the
gene
coding
for
collagen
VII
,
a
specialized
adhesion
component
of
the
dermal-epidermal
junction
zone
.
Both
recessive
and
dominant
forms
are
known
;
the
latter
account
for
about
40
%
of
cases
.
Patients
with
dominant
dystrophic
epidermolysis
bullosa
exhibit
a
spectrum
of
symptoms
ranging
from
mild
localized
to
generalized
skin
manifestations
.
Individuals
with
the
same
mutation
can
display
substantial
phenotypic
variance
,
emphasizing
the
role
of
modifying
genes
in
this
disorder
.
The
etiology
of
dystrophic
epidermolysis
bullosa
has
been
known
for
around
two
decades
;
however
,
important
pathogenetic
questions
such
as
involvement
of
modifier
genes
remain
unanswered
and
a
causative
therapy
has
yet
to
be
developed
.
Much
of
the
failure
to
make
progress
in
these
areas
is
due
to
the
lack
of
suitable
animal
models
that
capture
all
aspects
of
this
complex
monogenetic
disorder
.
Here
,
we
report
the
first
rat
model
of
dominant
dystrophic
epidermolysis
bullosa
.
Affected
rats
carry
a
spontaneous
glycine
to
aspartic
acid
substitution
,
p
.
G
1867
D
,
within
the
main
structural
domain
of
collagen
VII
.
This
confers
dominant-negative
interference
of
protein
folding
and
decreases
the
stability
of
mutant
collagen
VII
molecules
and
their
polymers
,
the
anchoring
fibrils
.
The
phenotype
comprises
fragile
and
blister-prone
skin
,
scarring
and
nail
dystrophy
.
The
model
recapitulates
all
signs
of
the
human
disease
with
complete
penetrance
.
Homozygous
carriers
of
the
mutation
are
more
severely
affected
than
heterozygous
ones
,
demonstrating
for
the
first
time
a
gene
-dosage
effect
of
mutated
alleles
in
dystrophic
epidermolysis
bullosa
.
This
novel
viable
and
workable
animal
model
for
dominant
dystrophic
epidermolysis
bullosa
will
be
valuable
for
addressing
molecular
disease
mechanisms
,
effects
of
modifying
genes
,
and
development
of
novel
molecular
therapies
for
patients
with
dominantly
transmitted
skin
disease
.
Diseases
Validation
Diseases presenting
"the lack of suitable animal models that capture all aspects of this complex monogenetic disorder"
symptom
dystrophic epidermolysis bullosa
You can validate or delete this automatically detected symptom
Validate the Symptom
Delete the Symptom